Saylanon, Zhyrone Ace L.

HRN: 24-02-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFUROXIME 750MG (VIAL)
11/07/2023
11/14/2023
IV
650mg
Q8h
Laceration
Waiting Final Action 
11/07/2023
CEFUROXIME 750MG (VIAL)
11/07/2023
11/14/2023
IV
670 Mg
Q8h
Laceration
Waiting Final Action 
11/08/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
11/08/2023
11/08/2023
IV
1 Amp
Now
For OR Use Of Wound Suturing
Waiting Final Action 
11/11/2023
MUPIROCIN 2%, 15G (TUBE)
11/11/2023
11/18/2023
TOPICAL
2%
BID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: